Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

MDxI Launches LabFile Data Resource

Published: Friday, July 25, 2014
Last Updated: Thursday, July 24, 2014
Bookmark and Share
New standard for defining and targeting US clinical laboratory universe.

Market Diagnostics International LLC has announced the availability of IVD Insights™ LabFile, a data resource that sets a new standard for defining the US clinical laboratory universe and identifying target In Vitro Diagnostics (IVD) customers.

LabFile is a proprietary database that provides IVD manufacturers with accurate and comprehensive information on sites performing clinical tests, relying on clear and consistent definitions of laboratory categories and institutional affiliations.

LabFile is based on MDxI’s extensive site research and industry knowledge and is a highly informative tool for defining market opportunities and targets.

“Our work with IVD clients indicated that even sophisticated companies had incomplete, often conflicting information about existing customers, and they were struggling to accurately identify and target new customers. Many also were spending considerable resources to update and refine their CRM systems, often with unsatisfactory results,” commented Kathi McGregor, President and Managing Partner of MDxI.

McGregor continued, “LabFile was developed to address these issues. Over the past two years, we obtained input from manufacturers about what was missing in their own databases and then invested thousands of hours in developing LabFile, the most rigorously designed and compiled clinical laboratory database to date. We also are providing customers with quarterly updates to capture the ever-changing nature of the laboratory market.”

Unlike other industry data resources, which assume that the 200,000+ CLIA licenses equal an equivalent number of unique laboratories, LabFile takes into account the expansion of health care delivery networks and resulting consolidation of laboratory testing.

Currently, LabFile identifies and classifies nearly 14,000 verified sites for targeting out of the estimated 18,000 US labs performing moderate to high complexity IVD testing. The number of verified, profiled sites will continue to grow as the product is expanded, with such added details as identifying sites that perform only CLIA-waived testing.

Updated quarterly, LabFile is a valuable resource for cleaning, maintaining, and reconciling current CRM data or establishing new CRM systems.

Reports are easily segmented and targeted for specific purposes, using clearly defined and standardized classification of laboratory types, subtypes, and network affiliations.

Coupled with MDxI’s IVD Insights Reports, LabFile presents the clearest picture of the configuration and depth of the US IVD market available.

To learn more about IVD Insights™ LabFile, visit Booth #1679 at the 2014 AACC Annual Meeting in Chicago, IL, July 27-31, 2014.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Autism, Cancer Share a Remarkable Number of Risk Genes
Researchers with the UC Davis Comprehensive Cancer Center, MIND Institute identify more than 40 common genes.
Number Of Known Genetic Risk Factors For Endometrial Cancer Doubled
An international collaboration of researchers has identified five new gene regions that increase a woman’s risk of developing endometrial cancer, one of the most common cancers to affect women, taking the number of known gene regions associated with the disease to nine.
Five New Breast Cancer Genes Found
Discovery of mutations paves the way for personalised treatment of breast cancer.
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Magnetic Nanoparticles May Reveal Early Traces Of Cancer
Rice University students’ computer program aids MD Anderson diagnostic initiative .
New Blood Test for The Earlier Diagnosis of Breast Cancer Spread
Researchers at University of Westminster have confirmed that a new blood test can detect if breast cancer has spread to other parts of the body.
Genetic Approach May Lead to New Treatments for Digestive Diseases
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
World-First Blood Test For Parkinson's
La Trobe University researchers have developed a world-first diagnostic blood test which could change the lives of people with Parkinson's disease.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!